Overview
Status
Active
Registry date
2025-03-28
Share capital
5,000.00 PLN
Registered address
ul. Ogrodowa 2A, 05-092 Kiełpin, Poland
Electronic delivery address
AE:PL-47728-40690-BDFBU-25
Financials
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
The financial statement for 2025 was filed on time.
- 202513/07/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Krzysztof Dubiel – Attorney-in-fact (joint)
Maciej Wieczorek – President of the Management Board
Małgorzata Stokrocka – Management Board Member
Manner of representation
The following are authorized to represent the company and make declarations on its behalf: 1. the President of the Management Board, acting individually; 2. two members of the management board, acting jointly; or 3. a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company Celon Bioinnovations.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed PharmaS.A. | $541,927,181.76 | adamed.com.pl | ||
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
Last updated: 2026-10-07